University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Stanton A. Glantz, PhD

Stanton A. Glantz, PhD

Professor, Department of Medicine; and Director, Center for Tobacco Control Research and Education, UCSF; Co-Leader, Tobacco Control Program, UCSF Helen Diller Family Comprehensive Cancer Center
American Legacy Foundation Distinguished Professorship in Tobacco Control, UCSF

Cancer Center Program Memberships

Tobacco Control

Research Summary

I am a widely recognized researcher with a reputation for identifying and pursuing high-impact questions that make practical contributions to tobacco control policy development, evaluation, and implementation. I am skilled in both qualitative and quantitative research methods, having written several books on tobacco control policy and two successful statistics textbooks. As Director of the UCSF Center for Tobacco Control Research and Education (CTCRE), I have extensive practical experience in developing and managing transdisciplinary academic programs and bringing together faculty from many disciplines. I have supervised a total of 96 fellows and graduate students during my career and am the Program Director of the CTCRE Postdoctoral Training Program in collaboration with Dr. Pamela Ling. I have published in a broad range of tobacco control areas, including economic models of the effects of tobacco control policies on health outcomes and health care costs, social and environmental determinants of smoking and smoking cessation, young adult smoking, and health effects of secondhand smoke, particularly on heart disease. I wrote the first papers based on analyses of previously secret tobacco industry documents (published in JAMA in 1995). Since then, I have worked with the UCSF Library to build the Legacy Tobacco Documents Library, which now exceeds 83 million pages (and is growing). The library is a major international research resource that has supported preparation of over 900 publications, including 134 authored by me, and the CTCRE is an internationally known training resource for tobacco document research that serves postdoctoral fellows and many others working in tobacco control. I am also the Principal Investigator of the UCSF Tobacco Center of Regulatory Science (TCORS), which brings together a broad multidisciplinary group of faculty and provides training opportunities and funds for pilot studies for trainees with an interest in tobacco regulatory science.

Education

University of Cincinnati, OH, BS, 1969, Aerospace Engineering
Stanford University, CA, MS, 1970, Applied Mechanics
Stanford University, CA, PhD, 1973, Applied Mechanics and Engineering Economic Systems
Stanford University, CA, Postdoc, 1975, Cardiology
University of California San Francisco, CA, Postdoc, 1977, Cardiovascular Research


Professional Experience

  • 1965-68
    Student trainee, NASA Manned Spacecraft Center, Houston
  • 1969
    Aerospace Engineer, NASA Manned Spacecraft Center, Houston, TX
  • 1977-80
    Assistant Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1981-82
    Associate Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1983-87
    Associate Professor of Medicine, Univ. of California, San Francisco
  • 1987-present
    Professor of Medicine, Univ. of California, San Francisco
  • 2002-present
    Director, UCSF Center for Tobacco Control Research and Education

Honors & Awards

  • (1960)
    Eagle Scout, Bronze Palm
  • (1964)
    Outstanding future teacher
  • (1964)
    Bausch and Lomb Science Award
  • (1968)
    Tau Beta Pi (engineering)
  • (1969-72)
    NSF Graduate Fellowship
  • (1975-77)
    Bay Area Heart Research Committee Senior Research Fellowship
  • (1977-82)
    NIH Research Career Development Award
  • (1978)
    Best Paper Published in Computer
  • (1986)
    Janssen Lecture of Society for Cardiac Anesthesia
  • (1992)
    Fellow, American College of Cardiology
  • (1992-1997)
    Associate Editor, Journal of the American College of Cardiology
  • (1996)
    James Madison Freedom of Information Award, Society of Professional Journalists
  • (1996)
    Alton Ochsner Award of Special Recognition
  • (1997)
    UCSF Chancellor's Award for Public Service
  • (1998)
    American Society of Addiction Medicine Annual Award
  • (1998)
    Gleitsman Foundation Citizen Activist Award
  • (1999)

    American Heart Association Rashkind Lecture
  • (1999)
    "Taking the Heat" Award, University of California Tobacco Related Diseases Research Program
  • (2000)
    Ralph R. Sachs Lecture, UCLA
  • (2000)
    Common Cause Public Service Achievement Award
  • (2000)
    Robert Wood Johnson Innovators in Substance Abuse Control
  • (2002)
    FAMRI Cahan Distinguished Professor Award
  • (2003)
    American Public Health Association, Alcohol and Other Drugs section Lifetime Achievement Award
  • (2005)
    Elected to Institute of Medicine

Selected Publications

  1. Lempert LK, Glantz SA. Heated tobacco product regulation under US law and the FCTC. Tob Control. 2018 Oct 05.
    View on PubMed
  2. Hiilamo H, Glantz S. Limited implementation of the framework convention on tobacco control's tobacco tax provision: global comparison. BMJ Open. 2018 Oct 02; 8(10):e021340.
    View on PubMed
  3. van der Eijk Y, Bialous S, Glantz SA. Authors' Response. Pediatrics. 2018 Oct; 142(4).
    View on PubMed
  4. Bhatta DN, Glantz S. Parental tobacco use and child death: analysis of data from demographic and health surveys from South and South East Asian countries. Int J Epidemiol. 2018 Oct 01.
    View on PubMed
  5. Bialous SA, Glantz SA. Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control. Tob Control. 2018 Sep 12.
    View on PubMed
  6. Popova L, Lempert LK, Glantz SA. Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims. Tob Control. 2018 Sep 12.
    View on PubMed
  7. Glantz SA. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control. 2018 Aug 21.
    View on PubMed
  8. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association Between Electronic Cigarette Use and Myocardial Infarction. Am J Prev Med. 2018 Aug 17.
    View on PubMed
  9. Ling PM, Glantz SA. Tobacco company strategies to identify and promote the benefits of nicotine. Tob Control. 2018 Aug 09.
    View on PubMed
  10. Egbe CO, Bialous SA, Glantz S. Role of stakeholders in Nigeria's tobacco control journey after the FCTC: lessons for tobacco control advocacy in low-income and middle-income countries. Tob Control. 2018 Jul 25.
    View on PubMed
  11. Barry RA, Glantz SA. Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard. Am J Public Health. 2018 Jul; 108(7):914-923.
    View on PubMed
  12. Apollonio DE, Glantz SA. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2018 Jun 28.
    View on PubMed
  13. Watkins SL, Glantz SA, Chaffee BW. Noncigarette Tobacco Products-Gateway or Diversion?-Reply. JAMA Pediatr. 2018 Jun 04.
    View on PubMed
  14. van der Eijk Y, Bialous SA, Glantz S. The Tobacco Industry and Children's Rights. Pediatrics. 2018 May; 141(5).
    View on PubMed
  15. Egbe CO, Bialous SA, Glantz S. FCTC Implementation in Nigeria: Lessons for Low and Middle-Income Countries. Nicotine Tob Res. 2018 Apr 06.
    View on PubMed
  16. Lempert LK, Glantz SA. Tobacco Industry Promotional Strategies Targeting American Indians/Alaska Natives and Exploiting Tribal Sovereignty. Nicotine Tob Res. 2018 Mar 12.
    View on PubMed
  17. Chaffee BW, Watkins SL, Glantz SA. Electronic Cigarette Use and Progression From Experimentation to Established Smoking. Pediatrics. 2018 Apr; 141(4).
    View on PubMed
  18. Glantz SA, Gardiner P. Local Movement to Ban Menthol Tobacco Products as a Result of Federal Inaction. JAMA Intern Med. 2018 Mar 05.
    View on PubMed
  19. Popova L, Thrul J, Glantz SA. Effects of Large Cigarette Warning Labels on Smokers' Expected Longevity. Am J Health Behav. 2018 Mar 01; 42(2):85-92.
    View on PubMed
  20. Orenstein DG, Glantz SA. Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. J Psychoactive Drugs. 2018 Jan-Mar; 50(1):19-32.
    View on PubMed

Go to UCSF Profiles, powered by CTSI